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PREVIOUSLY Calcutt and Payne (1954a, 1954b, 1954c) have described the
determination ofthe intracellular sites ofmetabolism of 3: 4-benzpyrene in mouse
and rat liver. These earlier experiments were limited to consideration of events
within the first 24 hours after application of the hydrocarbon. As an extension of
this work we have now examined the course ofevents in rat liver over longer time
intervals. The primary purpose of the investigation was to discover whether any
changes occurred in the overall distribution of metabolic sites and to determine
whether metabolism was a continuous process or dependent upon the presence
and integrity of any specific substrate.
MATERIALS AND METHODS.
The animals used throughout the experiments described below were rats,
aged 6-9 months, ofthe Wistar strain. The benzpyrene was applied as a colloidal
suspension in distilled water at a concentration of approximately 1 mg. per c.c.
In all experiments the animals were killed five hours after being treated with
benzpyrene. The livers were homogenised and fractionated into nuclei, mito-
chondria, microsomes and top, middle and bottom subfractions ofthe supernatant.
The fractionation procedures and subsequent examinations for the presence of
benzpyrene metabolites were carried out as in theearlierwork (Calcutt and Payne,
1954a, 1954b, 1954c.).
The terminology devised by Weigert and Mottram (1946) is used in referring
to the metabolic derivatives of benzpyrene. This is as below:
BpX1 8(0R1)-9(OH)-8, 9-dihydro-3: 4-benzpyrene
BpX2 8(0R1)-9(0R2)-8, 9-dihydro-3: 4-benzpyrene
BpF1 8(0R1)-3: 4-benzpyrene
where R1 and R2 are unknown radicals.
RESULTS.
The experiments comprising the work reported in this paper fall into groups
and are considered as such below. During the course of the experiments several
subsidiary points arose and findings in connection with these are given later.
First experiment.
A batch ofmale rats was injected weekly with an intraperitoneal dose of 2 mg.
of benzpyrene. Two rats were taken at weekly intervals and killed. The liversMETABOLISM OF 3: 4 BENZPYRENE
were fractionated and the presence of benzpyrene metabolites in the different
fractions determined. The detailed findings are shown diagrammatically in Fig. 1.
From this it will be seen that there is a change in the distribution ofsites at which
BpX1 and BpX2 are formed as the treatment is continued.
Second experiment.
This was a repetition of the previous experiment but using female animals.
Theresults are showninFig. 2. Herethe changesweremorenoticeable, metabolism
having ceased or fallen below detectable limits by the time seven doses had been
given.
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FIG. 1.-The distribution of benzpyrene metabolites in liver fractions from male rats.
Each determination is based on the pooled livers from two rats. Failure to detect benz-
pyrene or its derivatives is indicated by a dash.
Third experiment.
Female rats of the Wistar strain are much smaller than the males, so the
loading of benzpyrene per unit liver mass must have been greater in the second
experiment than in the first. So a further limited series of male rats was investi-
gated to see if metabolism of the hydrocarbon could be arrested by giving a
heavier dosage ofbenzpyrene. This time the animals were injected twice weekly,
2 mg. per animal being given on each occasion. Findings in respect ofmetabolism
occurring after several weeks ofthis treatment are shown in Fig. 3. Here again it
will be seen that metabolism completely ceased or fell below detectable limits.
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On various occasions during the above experiments BpF1 and its breakdown
product 8-OH benzpyrene have been found. These findings have been omitted
from the figures as both these products were shown by Weigert and Mottram
(1946) to be derived from the primary metabolites BpX, and BpX2.
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FIG. 2.-The distribution ofbenzpyrene metabolites inliver fractions fromfemale rats. Symbols
as in Fig. 1.
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FIG. 3.-The distribution of benzpyrene metabolites in liver fractions from male rats
(Experiment 3). Symbols as in Fig. 1.
Alternative metabolic pathways.
With the reduction or cessation of the formation ofBpXj and BpX2 it might
be expected that metabolism is diverted into alternative pathways. The extracts
of the various fractions. however, have given no indications of the presence of
any other benzpyrene derivatives. Equally, the animals themselves have shown
no signs of any increased retention of the unchanged hydrocarbon as the experi-
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FIG. 4. Protein concentrations of subfractions of the supernatant from female rat livers.
Each determination is based on the pooled livers from two rats. Of the 2 rats receiving 6 injections the liver of 1 was grossly necrotic.
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FIG. 5.-Protein concentrations ofsubfractions of the supernatant from male rat livers.
Symbols as in Fig. 4.
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ments have progressed. A possibility is that after metabolism is reduced the
hydrocarbon is excreted unchanged. This is supportedby the observation made in
this laboratory that rats which have been subjected to a number of injections of
benzpyrene show a faecal excretion of very little phenolic derivative together
with a relatively large amount of unchanged hydrocarbon. Freshly injected
animals, on the other hand, show a preponderance of the phenolic derivatives
accompanied by only small amounts of the parent benzpyrene.
Soluble proteins of liver.
During the first experimental series we were led to suspect a change in the
overall supernatant fraction from treated animals as compared with controls.
So in the two subsequent series the protein concentrations of the subfractions
were determined from measurements of their respective refractive indices. From
these the amounts of protein per unit mass of liver used were calculated. The
results for female animals are shown in Fig. 4 and the corresponding data for
males in Fig. 5. The results give an impression that there is a reduction in the
amounts of protein comprised in the top and middle subfractions. This point,
however, requires further corroboration, particularly since the overall architecture
of the liver alters with continued application of benzpyrene. After several weeks
of treatment the livers show an appreciable degree of round cell infiltration and
signs of degeneration, which means that the livers early in the experiment are not
strictly comparable to those used later.
Lipoproteinfractions.
After the high speed centrifugation required for separation of the supernatant
into subfractions. tubes containing material from untreated animals are found to
have a narrow surface layer of milky material. As this fraction was noticed to be
absent in some experimental runs a record was maintained of its presence or
otherwise. The appearance and behaviour of this fraction suggested its possible
lipoprotein nature. Some ofthe material was extracted from a batch ofuntreated
rats and then purified by further centrifugation after admixture with 1.3 per cent
sodium chloride solution. Tests gave the following results.
The presence of unsaturated fatty acids was shown by the blackening of
osmic acid.
An ether extract gave a white deposit when diluted with twice its volume
of acetone. This indicates lecithin, which was confirmed by taking up the
deposit in water and obtaining typical myelin figures.
The acetone-ether fraction remaining from the above experiment gave a
positive Lieberman-Burchard test for cholesterol.
A Rosenheim bismuth test for free choline was negative.
It was concluded that this fraction must be essentially the lipoproteins from
the liver cells.
From the protocols of the experiments a table has been drawn showing our
findings in respect of this fraction. This appears below as Table I. Although no
quantitative measurements have been attempted it will be seen that this fraction
either disappears completely or is much reduced.
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TABLE I.-The Lipoprotein Fractions from the Supernatant Fraction of Livers of
Rats Receiving Weekly Injections of Colloidal Benzpyrene.
Female rats. Male rats.
Number of Appearance of Number of Appearance of
injections. lipoprotein fraction. injections. lipoprotein fraction.
1 As normal . 6 Trace only
2 Absent . 8 Absent
3 Small amount only . 10 ,,
4 Absent . 12 Small amount only
5 ,,. 14 ,
6 Completely absent . 16 Small amount present
7 Absent
8 Completely absent
Descriptions of fractions are those recorded in the protocols of experiments.
DISCUSSION.
The experimental results given above only represent a preliminary survey of
an extensive field, nevertheless, a number of interesting points have arisen. Of
these the most important is perhaps, that the action of benzpyrene on the cell
involves a number of processes which may or may not be related.
The change in the sites at which the two benzpyrene derivatives BpX1 and
BpX2 are formed suggests that there is no specificity about the factor or factors
determining which derivative is produced, but that the sequence of events is
conditioned by the previous history of the fraction in question. This variation
in the pattern may well be the counterpart to Boyland and Wiltshire's (1953)
finding that with repeated dosing of naphthalene to rats changes occurred in the
relative proportions of naphthalene diol and naphthylglucuronide excreted.
These particular experiments were only run over a limited period, but the results
presented suggest a tailing off in overall metabolism towards the end of the
investigation. Since we have found an apparent complete cessation ofmetabolism
ofbenzpyrene it may be important to determine whether a similar state of affairs
can be attained using the non-carcinogenic polycyclic hydrocarbons.
The reasons for the apparent cessation in the metabolism of benzpyrene are
not discernible from the present experiments. It is tempting to ascribe the pheno-
menon to the elimination of enzyme systems concerned in the oxidation of the
hydrocarbon, but this appears very unlikely as Casu et al. (1951) have offered
convincing evidence that the metabolic oxidation of benzpyrene is completely
independent of enzyme systems. This leaves two alternative explanations. The
first, that the benzpyrene ceases to penetrate the cell after a time, is disposed of
by the finding of the unchanged hydrocarbon in the various fractions at a time
when metabolism no longer occurs. The second, that some unidentified grouping
in the cell fractions is eliminated, cannot yet be checked. It is hoped that further
evidence may be obtained from a more detailed examination of the residual cell
fractions which is now being undertaken.
The possible changes in amounts of soluble proteins in the livers of treated
animals resembles findings with other carcinogenic agents. Using 2-acetyl-
aminofluorene Laird and Miller (1953) found a fall in the protein content of the
supernatant from liver four weeks after commencement of treatment. Later a
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return to a more normal level occurred. Studies by Price, Miller, Miller and Weber
(1950) are suggestive of a small decrease in the protein content ofthe supernatant
fraction from rat livers treated with azo dyes. The supernatant fraction from
hepatic tumours induced by azo dyes has been shown by Sorof and Cohen (1951)
to possess a decidedly lower complement of the lower molecular weight proteins
than that from normal liver. In the present experiments it is also the lower
molecular weight proteins-i.e. the slower sedimenting fractions-which show
signs of change.
The reduction in the lipoprotein fraction associated with the supernatant is
also interesting, in that lecithinwhich forms part of this fraction contains choline.
The absence of choline has been reported by Copeland and Salmon (1946) to result
in liver tumours, whilst its presence protects against fatty infiltration and cirrhosis
of the liver. Both of these conditions are known to be intimately involved with
carcinogenesis of the liver. Whilst benzpyrene is not recognised as causing such
changes the closely related hydrocarbon 1: 2: 5: 6-dibenzanthracene was shown
by Claude (1937) and Burrows and Boyland (1938) to cause cirrhosis in rabbit
liver.
The evidence which has become available from this present preliminary
investigation suggests a number ofpoints for further examination. Obviously the
question of the actual substrates involved in the metabolic processes must be
pursued further. Equally the fact that benzpyrene induces changes in liver
components similar to those produced by other carcinogenic agents demands
further experiments. In this connection it must be remembered that benzpyrene
has never been found to induce liver tumours, although the evidence summarised
by Berman (1951, p. 119) shows that related polycyclic hydrocarbons can act in
this fashion. Experiments designed to test the carcinogenicity of benzpyrene
for liver are in progress and solution of this problem will aid in evaluating the
possible relationship of some of the effects produced by the hydrocarbon to the
carcinogenic process itself.
SUMMARY.
1. Wistar strain rats have been injected intraperitoneally at weekly intervals
with colloidal benzpyrene.
2. Determinations of benzpyrene metabolites in the various intracellular
fractions at weekly intervals have shown that variations occur in the sites of
formation of the two derivatives BpX1 and BpX2. Finally all metabolism ceases
or falls below detectable limits.
3. Indications were found of a fall in the amounts of the lower molecular
weight proteins of the supernatant fraction.
4. Lipoproteins associated with the supernatant fractions were found to be
much reduced or to disappear.
5. The experimental results and their significance are briefly discussed.
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